This report provides exclusive insights into the COVID-19 impact on the Travel Vaccine Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Travel Vaccine Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Travel Vaccine Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on the travel
vaccine market provides an in-depth analysis of segments and sub-segments in the
global as well as regional travel vaccine market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
travel vaccine market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
travel vaccine market. According to the report, the global travel vaccine
market is projected to grow at a CAGR of 9.2% over the forecast period of
2019-2025.
Market Insight
The number of peoples traveling worldwide has increased
substantially since the mode of transport via air, land, and sea has developed
considerably. People travel abroad for business, holiday, studying, medical
care, adventure, visiting friends and relatives, etc. thereby carrying with
them pathogens and vectors resulting in pandemic diseases. Moreover, there are
also concerns regarding health issues arising from disease outbreak or natural
disaster to certain international destinations thereby affecting travelers’
health. For e.g. outbreak of yellow fever in Nigeria in September 2017. As a
result, countries established entry requirements on vaccination for travelers
to protect from spreading or importing the disease. Thus, one of the effective
methods for travelers to prevent disease is vaccination. Vaccination is a
process of introducing vaccine i.e. a biological preparation that stimulates
the body’s immune system to a particular disease. Travel vaccines also referred
to as travel immunizations are shots that have to be taken by travelers to help
protect them from infectious diseases before they visit particular areas of the
world. However, a travel vaccine should be taken 1 month before traveling.
According to the UN World Tourism Organization, in 2018
international tourist arrival has reached up to 1.4 billion. This enormous rise
in the number of tourists is the major factor enhancing the travel vaccine
market. In addition to this, other factors such as meeting travel expenses,
expanding business models and visa facilitation bring about an exponential leap
in traveling which in turn drives the travel vaccine market. Furthermore, stringent
regulations for health safety by regional government bodies also fuelling the
growth of the market. However, on the other hand, high cost and unskillful
resource persons for the production of the disease-specific vaccines may hamper
the market. Moreover, advancement in technology, awareness programs by
government and private organizations, an outbreak of diseases come up with
greater opportunities for the growth of the travel vaccine market during the
forecast period.
On the basis of region, the market is categorized into North
America, Europe, Asia Pacific, and RoW. North America is dominating the travel
vaccine market due to good reimbursement policies and a large number of key
players in this region. The European travel vaccine market expects to boost
owing to raising awareness of the diseases among the population as well as
research on the development of disease-specific vaccines. Asia Pacific market
will surge during the forecast period because of rising funds and an increase
in the number of people traveling abroad for studies, careers, medical care,
etc.

Segment Covered
The report on the global travel vaccine market covers segments such as
composition type and disease type. On the basis of composition, the sub-markets include
mono vaccine, and combination vaccines. On the basis of type, the sub-markets
include attenuated vaccines, inactive vaccines, subunit vaccines, toxoid
vaccines, conjugate vaccines, DNA vaccines, and recombinant vector vaccines. On the basis of disease type, the sub-markets include hepatitis A, hepatitis B, typhoid, and paratyphoid fever,
meningococcal disease, yellow fever, rabies, Japanese encephalitis, and others
Companies Profiled:
The report provides profiles of the companies in the market such
as GlaxoSmithKline plc, Pfizer Inc., F. Hoffman-La Roche Ltd., Merck & Co.,
Inc., Abbott Laboratories, Sanofi S.A, Dynavax Technologies Corporation,
Shenzhen Kangtay Biological Products Co., Baxter International, Takeda
Pharmaceuticals U.S.A., Inc., and other companies.
Report Highlights:
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of travel vaccine
market. Moreover, the study highlights current market trends and provides
forecast from 2019-2025. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.